H., Safeek, R., Ockerman, K., et al
Retatrutide dosage In phase 2 clinical trials, retatrutide was given in the following doses: 1mg, 2mg or 4mg (starting dose) 1mg, 4mg, 8mg or 12mg per week (maintenance dose) 12mg per week (maximum dose) The dose escalation was similar to other weight loss medications, with the retatrutide dose increasing every 4 weeks
Summarizing the data on the mechanisms of necroptosis, it can be noticed that this kind of programmed cell death requires mitochondrial and cytosolic ROS [216, 217]
Topical treatments may also be used
Chen L, Capone DL, Jeffery DW (2018) Chiral analysis of 3-sulfanylhexan-1-ol and 3-sulfanylhexyl acetate in wine by high-performance liquid chromatography-tandem mass spectrometry
The initial approved regimen was 5 g subcutaneous injection twice daily, given within 60 minutes before morning and evening meals, titratable to 10 g BID